17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The mammalian target of rapamycin (mTOR) signal controls innate and adaptive immune response in multiple immunoregulatory contexts. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of myeloid cells of potent immunosuppressive capacity. In this study, we aimed to investigate the role of MDSCs in the protection of acute kidney injury (AKI) and the regulation of mTOR signal on MDSC's protective role in this context. In mice AKI model, rapamycin administration was associated with improved renal function, restored histological damage and decreased CD4 + and CD8 + T-cell infiltration in kidney tissue. MDSCs, especially CD11b +Ly6G +Ly6C low G-MDSCs were recruited to the injured kidney following the interaction of CXCL1, CXCL2 and their receptor CXCR2 after inhibiting mTOR signal with rapamycin treatment. The adoptive transfer of rapamycin-treated MDSCs into the mice with AKI significantly improved the renal function, ameliorated histologic damages and limited the infiltration of T cells in kidney tissue. In addition, the expression of pro-inflammatory cytokines IL-1 β and IFN- γ mRNA was downregulated while the expression of TGF- β1 and Foxp3 mRNA was upregulated in kidney tissue after transferring rapamycin-treated MDSCs. Adoptive transfer of rapamycin-treated MDSCs also downregulated the serum levels of IL-1 β, IL-6 and IFN- γ and upregulated the serum levels of TGF- β1 compared with the IR group and PBS-treated MDSC group. In in vitro study, inhibiting mTOR signal regulated the induction of MDSC towards the CD11b +Ly6G +Ly6C low G-MDSC subset. The ability to suppress T-cell proliferation of both bone marrow–derived CD11b +Ly6G +Ly6C low G-MDSCs and CD11b +Ly6G -Ly6C high M-MDSCs was enhanced by mTOR signal inhibition via upregulating the expression of Arginase-1 and iNOS. Accordingly, both G-MDSCs and M-MDSCs presented downregulated runx1 gene expression after rapamycin treatment. Taken together, our results demonstrated that MDSCs ameliorated AKI and the protective effect was enhanced by mTOR signal inhibition via promoting MDSCs recruitment, regulating the induction of MDSCs and strengthening their immunosuppressive activity.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

          Antigen-specific CD8+ T-cell tolerance, induced by myeloid-derived suppressor cells (MDSCs), is one of the main mechanisms of tumor escape. Using in vivo models, we show here that MDSCs directly disrupt the binding of specific peptide-major histocompatibility complex (pMHC) dimers to CD8-expressing T cells through nitration of tyrosines in a T-cell receptor (TCR)-CD8 complex. This process makes CD8-expressing T cells unable to bind pMHC and to respond to the specific peptide, although they retain their ability to respond to nonspecific stimulation. Nitration of TCR-CD8 is induced by MDSCs through hyperproduction of reactive oxygen species and peroxynitrite during direct cell-cell contact. Molecular modeling suggests specific sites of nitration that might affect the conformational flexibility of TCR-CD8 and its interaction with pMHC. These data identify a previously unknown mechanism of T-cell tolerance in cancer that is also pertinent to many pathological conditions associated with accumulation of MDSCs.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.

            Myeloid-derived suppressor cells (MDSCs) are one of the main cell populations responsible for regulating immune responses. MDSCs accumulate during tumor progression, autoimmunity, chronic infection and other pathological conditions, and can potently suppress T cell function. Recent studies have demonstrated the ability of MDSCs to modulate the activity of NK and myeloid cells and have implicated MDSCs in the induction of regulatory T cells. Here, we discuss recent findings that describe the molecular mechanisms that regulate the expansion and function of MDSCs, as well as recent attempts to use MDSCs in cell therapy for different pathologic conditions. Copyright © 2010 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Subsets of myeloid-derived suppressor cells in tumor-bearing mice.

              Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of cells that play a critical role in tumor associated immune suppression. In an attempt to identify a specific subset of MDSC primarily responsible for immunosuppressive features of these cells, 10 different tumor models were investigated. All models showed variable but significant increase in the population of MDSC. Variability of MDSC expansion in vivo matched closely the effect of tumor cell condition medium in vitro. MDSC consists of two major subsets of Ly6G(+)Ly6C(low) granulocytic and Ly6G(-)Ly6C(high) monocytic cells. Granulocytic MDSC have increased level of reactive oxygen species and undetectable level of NO whereas monocytic MDSC had increased level of NO but undetectable levels of reactive oxygen species. However, their suppressive activity per cell basis was comparable. Almost all tumor models demonstrated a preferential expansion of granulocytic subset of MDSC. We performed a phenotypical and functional analysis of several surface molecules previously suggested to be involved in MDSC-mediated suppression of T cells: CD115, CD124, CD80, PD-L1, and PD-L2. Although substantial proportion of MDSC expressed those molecules no differences in the level of their expression or the proportion, positive cells were found between MDSC and cells from tumor-free mice that lack immune suppressive activity. The level of MDSC-mediated T cell suppression did not depend on the expression of these molecules. These data indicate that suppressive features of MDSC is caused not by expansion of a specific subset but more likely represent a functional state of these cells.
                Bookmark

                Author and article information

                Journal
                Cell Death Dis
                Cell Death Dis
                Cell Death & Disease
                Nature Publishing Group
                2041-4889
                March 2017
                23 March 2017
                1 March 2017
                : 8
                : 3
                : e2695
                Affiliations
                [1 ]Department of Urology, Zhongshan Hospital, Fudan University , Shanghai, China
                [2 ]Shanghai Key Laboratory of Organ Transplantation , Shanghai, China
                [3 ]Shanghai Public Health Clinical Center, Fudan University , Shanghai, China
                [4 ]Department of Transfusion, Zhongshan Hospital, Fudan University , Shanghai, China
                Author notes
                [* ]Department of Urology, Zhongshan Hospital, Fudan University and Shanghai Key Laboratory of Organ Transplantation , 180 Fenglin Road, Shanghai 200032, China. Tel: +862 164 037287; Fax: +862 164 037269; E-mail: esuperyc@ 123456163.com , yang.cheng1@ 123456zs-hospital.sh.cn or E-mail: tyzhu_dr@ 123456163.com , tyzhu@ 123456fudan.edu.cn , zhu.tongyu@ 123456zs-hospital.sh.cn
                [* ]Department of Urology and Department of Transfusion, Zhongshan Hospital, Fudan University and Shanghai Key Laboratory of Organ Transplantation , 180 Fenglin Road, Shanghai 200032, China. Tel: +862 164 041990; Fax: +862 164 037269; E-mail: rong.ruiming@ 123456zs-hospital.sh.cn
                [5]

                These authors contributed equally to this work.

                Article
                cddis201786
                10.1038/cddis.2017.86
                5386577
                28333137
                ae0bf001-6f6c-426e-bdc3-c1852c9eab74
                Copyright © 2017 The Author(s)

                Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

                History
                : 12 September 2016
                : 06 February 2017
                : 09 February 2017
                Categories
                Original Article

                Cell biology
                Cell biology

                Comments

                Comment on this article